期刊文献+

5-乙酰胺甲基-3-[3-氟-4-(1-哌嗪基苯基)]异噁唑啉的合成 被引量:4

Synthesis of 5-(Acetamidomethyl)-3-[3-fluoro-4-(1-piperazinyl)phenyl] isoxazoline
下载PDF
导出
摘要 以3,4-二氟苯甲醛、盐酸羟胺为原料,经缩合反应、氯代反应制得3,4-二氟苯肟氯代物(3);以烯丙基胺为原料经乙酰化反应制得乙酰烯丙基胺(4);化合物3与化合物4经环合反应、哌嗪取代反应合成终产物5-乙酰胺甲基-3-[3-氟-4-(1-哌嗪基苯基)]异噁唑啉(1)。总收率为30.2%,纯度为99.1%(HPLC)。 The title compound I is an useful intermediate of isoxazolyl anti-microbial agents. It could be synthesized in several steps. Firstly, condensation of 3,4-Difluorobenzaldehyde and hydroxylamine hydrochloride followed by chlorination with NCS gave chlorinated 3,4- difluorobenzoxime _3. Secondly, reaction of allylamine with acetyl chloride gave acetyl allylamine 4. Finally, title compound 1 was obtained from 3 and 4 in an overal yield of 30.2% (based on 3,4difluorobenzaldehyde) with a purity of 99.1% (HPLC).
出处 《精细化工中间体》 CAS 2009年第3期31-33,共3页 Fine Chemical Intermediates
基金 国家科技"重大新药创制"第二批课题资助项目(2009ZX09103-078) 天津市科技计划资助项目(09ZCKFSH01300)
关键词 5-乙酰胺甲基-3-[3-氟-4-(1-哌嗪基苯基)]异噁唑啉 3 4-二氟苯甲醛 抗菌药 5- (acetamidomethyl)-3- [ 3-fluoro-4- ( 1-piperazinyl)phenyl ] isoxazoline 3,4-difluorobenzaldehyde antimicrobial agent
  • 相关文献

参考文献6

  • 1赵瑞萍,何贵山.细菌的耐药性及其对策[J].甘肃医药,2008,27(6):66-68. 被引量:3
  • 2Xiong Y Q,Yeaman M R,Bayer A S.Linezolid:a new antibiotic[J].Drugs of Today,2000,36(9):631-639.
  • 3李荣坡,周伟澄.噁唑烷酮类抗菌药物构效关系新进展[J].中国新药杂志,2003,12(9):694-700. 被引量:9
  • 4Barbachyn M R,Morris J,Wishka D G,et al.Substituted aminophenyl isoazoline derivatives useful as antimicrobials[P].WO:9 941 244,1999-08-19.
  • 5Kleinman E F.3-Aryl-2-Isoxazolines as antiinflammatory agents[P].WO:9 514 680,1995-06-01.
  • 6Farrerons G C,Lagunas A C.Fernandez S A,et al.Substituted isoxazoles and the use thereof as Antibiotics[P].WO:03 008 395,2003-01-30.

二级参考文献41

  • 1赖晓全,王洪波.肠球菌的临床分布及耐药性分析[J].实用医学杂志,2005,21(2):203-205. 被引量:3
  • 2李娟,冯晖,赵进.肠球菌的临床分布特征及耐药性分析[J].实用医技杂志,2005,12(09A):2354-2355. 被引量:8
  • 3姚开虎,俞桑洁,沈叙庄,佟月娟,高薇,杨永弘.北京地区青霉素不敏感肺炎链球菌分子流行病学的初步探讨[J].中华儿科杂志,2005,43(9):671-675. 被引量:6
  • 4Zhou J, Mortell K,Bore R,et M. Combinatiorial lead optimization of oxazolidinones: In vitro activities of novel 5-amidomethyt thiomorpholine S-oxide ang S, S-dioxide phenyloxazolidinones[A]. Proceedings of 42nd Interscience Conference on Antimicraobial Agents and Chemotherapy(ICAAC) ASM[C]. San Diego,2002. Ahs F- 1319.
  • 5Kuho A,Press B,Luehr GW,et al. In vitro activity of novel oxazolidinones against chlamydia [A]. Proceedings of 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) ASM[ C]. San Diego,2002. Abs F- 1322.
  • 6Tokuyama R, Takahashi Y, Tomita Y, et al. Structure-activity relationship(SAR) studies on oxazolidinone antibacterial agents.1. Conversion of 5-substituent on oxazolidinone [ J ]. Chem Phrm Bull ,2001,49(4) : 347 - 352.
  • 7Tokuyama R, Takahashi Y, Tomita Y, et al. Structure-activlty relatiortship(SAR) studies on oxazolidinone antibacterial agents.2. Relationship between lipophiliclty and antibacterial activity in 5-thioearbonyl oxazolidinone [ J ]. Chem Pharm Bull, 2001,49(4) :353 - 360.
  • 8Tokuyama R, Takahashi Y, Tomita Y, et al. Structure-activity relationship(SAR) studies on oxazolidinone antibacterial agents.3. Synthesis and evaluation of 5-thiocarbarnate oxazolidinones[J]. Chem Pharm Bull ,2001,49(4) :361 - 367.
  • 9Barry GM. Antibacterial oxazolidinane derivatives [P]. WO: 9964416,1999 - 12 - 16.
  • 10Barry GM.Preparation of new[ (heteroeyclylamino)methyl] oxazolidinones as antibacterials[ P ]. WO: 0021960,2000 - 04 - 20.

共引文献10

同被引文献29

  • 1赵鑫,陈晓光.肿瘤治疗分子靶点Hsp90研究进展[J].国外医学(肿瘤学分册),2004,31(8):594-597. 被引量:3
  • 2张珏,付晓钟,袁牧.1-(2-硝基苯基)哌嗪盐酸盐的合成[J].贵阳医学院学报,2001,26(3):210-211. 被引量:3
  • 3刘毅,王颖,刘晓丹,杨平地,于晓妉.热休克蛋白90抑制剂17-AAG诱导K562细胞凋亡作用的研究[J].中华血液学杂志,2006,27(12):809-812. 被引量:7
  • 4朱翔,陈志龙,李焰.氯化苯甲醛肟的简便合成[J].湖北大学学报(自然科学版),2007,29(2):164-166. 被引量:1
  • 5Charles E, Alicia A, Christine S, et al. Crystal structure of an Hsp90 Geldanamycin complex: targeting of a protein chaperone by an antitumor agent [J]. Cell, 1997, 89(2): 239-250.
  • 6GeJ, Normant E, PorterJ R, etal. Design, synthesis, and biological evaluation of hydroquinone derivatives of 17-amino 17-demethoxygeldanamyein as potent, water-soluble inhibitors of Hsp90 [J]. J Med Chem, 2006, 49(17): 4606-4615.
  • 7Brough P A, Aherne W, Barril X, et al. 4, 5-Diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer[J]. J Med Chem, 2008, 51 (2): 196- 218.
  • 8Suzanne A E, Andy M, FlorenceI R,etal. NVP-AUY922 A novel heat shock protein 90 inhibitor active against xeno graft tumor growth, angiogenesis, and metastasis [J]. Cancer Res, 2008, 68(8): 2850-2860.
  • 9Wright L, Barril X, Dymock B, etal. Structure-activity rela tionships in purine-based inhibitor binding to hsp90 isoforms [J]. Chem Biol, 2004, 11(6): 775-785.
  • 10张峥,李忠.异噁唑衍生物合成及其生物活性[J].农药研究与应用,2007,11(4):21-26. 被引量:6

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部